HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021.
Fiche publication
Date publication
juin 2024
Journal
Cancer epidemiology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DALSTEIN Véronique
Tous les auteurs :
Mirghani H, Tendron A, Auperin A, Casiraghi O, Classe M, Badoual C, Legoupil C, Puech J, Veyer D, Dalstein V, Pere H, Gorphe P
Lien Pubmed
Résumé
France has the sixth highest incidence of oropharyngeal cancer (OPC) in Europe, but the epidemiological impact of high-risk HPV (HR-HPV) remains poorly documented. The objective of our study was to assess the proportion of OPCs caused by HR-HPV in Paris, and its suburbs, over the four past decades. This area accounts for almost one-fifth of the total population of France.
Mots clés
Cancer(s), Epidemiology, France, Human papillomavirus (HPV), Neoplasm(s), Oral/oropharynx/oropharyngeal, Prevalence, Tonsil/tonsillar
Référence
Cancer Epidemiol. 2024 06 19;91:102603